Through cell proliferation arrest and apoptosis induction, navtemadlin prevented the in vivo growth of numerous tumor xenografts and caused complete and durable regression of MDM2-amplified SJSA-1 sarcoma tumors [71]. The gene discussed is MDM2; the disease is sarcoma.